Abstract
A palpable purpura developed on the legs and lower abdomen of a woman of 54 five days after she was treated with anistreplase anisoylated plasminogen streptokinase activator complex (APSAC) for an acute myocardial infarction. Histological examination of a skin biopsy specimen taken 6 days after treatment showed leucocytoclastic vasculitis. The rash resolved within two weeks and there were no other complications.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alexopoulos D., Raine A. E., Cobbe S. M. Serum sickness complicating intravenous streptokinase therapy in acute myocardial infarction. Eur Heart J. 1984 Dec;5(12):1010–1012. doi: 10.1093/oxfordjournals.eurheartj.a061602. [DOI] [PubMed] [Google Scholar]
- Bucknall C., Darley C., Flax J., Vincent R., Chamberlain D. Vasculitis complicating treatment with intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Br Heart J. 1988 Jan;59(1):9–11. doi: 10.1136/hrt.59.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Noel J., Rosenbaum L. H., Gangadharan V., Stewart J., Galens G. Serum sickness-like illness and leukocytoclastic vasculitis following intracoronary arterial streptokinase. Am Heart J. 1987 Feb;113(2 Pt 1):395–397. doi: 10.1016/0002-8703(87)90287-0. [DOI] [PubMed] [Google Scholar]
- Totty W. G., Romano T., Benian G. M., Gilula L. A., Sherman L. A. Serum sickness following streptokinase therapy. AJR Am J Roentgenol. 1982 Jan;138(1):143–144. doi: 10.2214/ajr.138.1.143. [DOI] [PubMed] [Google Scholar]